Update of the statement on safety of cannabidiol as a novel food
Abstract During the assessment of cannabidiol (CBD) as a novel food, in 2022 the NDA Panel identified significant data gaps. Concerns focused on potential adverse effects on the liver, gastrointestinal tract, endocrine, nervous and reproductive systems.
EFSA Panel on Nutrition +33 more
wiley +1 more source
The Rab3 family proteins in age-related neurodegeneration: unraveling molecular pathways and potential therapeutic targets. [PDF]
He H, Ai R, Fang EF, Palikaras K.
europepmc +1 more source
Dopamine and serotonin neurotransmissions exert complementary control over primate approach and avoidance. [PDF]
Gauthier L +10 more
europepmc +1 more source
Brain-Derived Neurotrophic Factor Trafficking via the Regulated Secretory Pathway: Mechanisms and Disease Implications. [PDF]
Ewell SN.
europepmc +1 more source
Pterostilbene restores mitochondrial retrograde signaling to activate protective stress responses in Parkinson's disease. [PDF]
Zeng F, Li W, Yang L, Yao L, Wang X.
europepmc +1 more source
Estrogen modulates reward prediction errors and reinforcement learning. [PDF]
Golden CEM +9 more
europepmc +1 more source
ACE2: Friend or Foe in Post-COVID-19 Neurodegeneration? [PDF]
Kononova SV +4 more
europepmc +1 more source
Opposite kinetics of L-leucine and L-phenylalanine induced insulin release studies with the perfused rat pancreas [PDF]
Landgraf, R. +3 more
core
Copper, Cuproptosis, and Neurodegenerative Diseases. [PDF]
Genchi G +4 more
europepmc +1 more source
Proteomic Exploration of L1CAM<sup>+</sup>-Extracellular Vesicles from Plasma of Manifest and Prodromal Parkinson's Disease. [PDF]
Xylaki M +10 more
europepmc +1 more source

